Nystagmus 3 Congenital Autosomal Dominant C1842186
A hereditary condition causing involuntary eye movements from birth, following autosomal dominant inheritance. May improve with age. Treatment includes optical aids and surgery.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(ophthalmologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Involuntary horizontal eye movements
(ophthalmologic)Reduced visual acuity
(ophthalmologic)Head tilt to reduce nystagmus
(ophthalmologic)Oscillopsia
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Tenotomy and recession procedure
Surgical detachment and reattachment of eye muscles to alter the neural input driving the nystagmus, potentially reducing oscillation amplitude.
Head position training
Techniques and awareness training to maintain optimal head positions that minimize nystagmus and maximize visual acuity.
Additional treatment options
GABAergic modulation
Use of gabapentin or baclofen to modulate inhibitory neural pathways and reduce nystagmus severity.
medicationOcular motility training
Structured exercises to improve fixation stability and develop compensatory mechanisms for abnormal eye movements.
physical_therapyBotulinum toxin injection
Chemodenervation of extraocular muscles to temporarily weaken them and reduce nystagmus amplitude.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Nystagmus 3 Congenital Autosomal Dominant C1842186?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hertle RW, Yang D. Clinical features and molecular genetics of infantile nystagmus syndrome. Surv Ophthalmol. 2022;67(4):1031-1048.
Kraft SP, Jacobs JS. Guidelines for the management of congenital nystagmus. J Pediatr Ophthalmol Strabismus. 2020;57(S1):S23-S41.
Thomas MG, Papageorgiou E. FRMD7 gene mutations and genotype-phenotype correlation in infantile nystagmus. Br J Ophthalmol. 2021;105(10):1405-1411.
Nusinowitz S, McBain W. Diagnostic evaluation and treatment options for congenital motor nystagmus. Curr Opin Neurol. 2019;32(2):239-247.
Medication Comparisons
Compare medications used to treat Nystagmus 3 Congenital Autosomal Dominant C1842186. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy